{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T17:48:48Z","timestamp":1775324928909,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s40744-021-00402-z","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T16:04:45Z","timestamp":1638893085000},"page":"265-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still\u2019s Disease in the U.S. Real-World Settings"],"prefix":"10.1007","volume":"9","author":[{"given":"Peter","family":"Hur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raluca","family":"Ionescu-Ittu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameur M.","family":"Manceur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen G.","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Cammarota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jipan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Nakasato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navneet","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5717-136X","authenticated-orcid":false,"given":"Alexei A.","family":"Grom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"402_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpeds.2016.06.056","volume":"177","author":"S Shenoi","year":"2016","unstructured":"Shenoi S, Wallace CA. Diagnosis and treatment of systemic juvenile idiopathic arthritis. J Pediatr. 2016;177:19\u201326.","journal-title":"J Pediatr"},{"key":"402_CR2","first-page":"125","volume":"8","author":"S Grevich","year":"2017","unstructured":"Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolesc Health Med Ther. 2017;8:125\u201335.","journal-title":"Adolesc Health Med Ther"},{"issue":"5","key":"402_CR3","first-page":"920","volume":"36","author":"S Shenoi","year":"2018","unstructured":"Shenoi S, Horneff G, Cidon M, et al. The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart review. Clin Exp Rheumatol. 2018;36(5):920\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"402_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/ard.54.7.587","volume":"54","author":"G Magadur-Joly","year":"1995","unstructured":"Magadur-Joly G, Billaud E, Barrier JH, et al. Epidemiology of adult Still\u2019s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis. 1995;54(7):587\u201390.","journal-title":"Ann Rheum Dis"},{"key":"402_CR5","first-page":"271569","volume":"2012","author":"R Gurion","year":"2012","unstructured":"Gurion R, Lehman TJ, Moorthy LN. Systemic arthritis in children: a review of clinical presentation and treatment. Int J Inflam. 2012;2012:271569.","journal-title":"Int J Inflam"},{"issue":"7","key":"402_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol. 2011;7(7):416\u201326.","journal-title":"Nat Rev Rheumatol"},{"key":"402_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1546-0096-8-20","volume":"8","author":"LN Moorthy","year":"2010","unstructured":"Moorthy LN, Peterson MG, Hassett AL, Lehman TJ. Burden of childhood-onset arthritis. Pediatr Rheumatol Online J. 2010;8:20.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"402_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res. 2011;63(4):465\u201382.","journal-title":"Arthritis Care Res"},{"key":"402_CR9","unstructured":"US Food and Drug Administration. Actemra (tocilizumab). Prescribing Information. 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/125472s044lbl.pdf. Accessed 15 Sept 2021."},{"key":"402_CR10","unstructured":"European Medicines Agency. Ilaris (canakinumab) European public assessment reports summary. 2020. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ilaris. Accessed 15 Sept 2021."},{"key":"402_CR11","unstructured":"US Food and Drug Administration. Ilaris (Canakinumab). Prescribing Information. 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/125319s100lbl.pdf. Accessed 15 Sept 2021."},{"issue":"25","key":"402_CR12","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. NEJM. 2012;367(25):2396\u2013406.","journal-title":"NEJM"},{"issue":"2","key":"402_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Quartier P, Wulffraat N, et al. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum. 2012;64(2):557\u201367.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"402_CR14","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2020-217155","volume":"79","author":"C Kedor","year":"2020","unstructured":"Kedor C, Listing J, Zernicke J, et al. Canakinumab for treatment of adult-onset still\u2019s disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis. 2020;79(8):1090\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"402_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12969-021-00605-2","volume":"19","author":"P Hur","year":"2021","unstructured":"Hur P, Lomax KG, Ionescu-Ittu R, et al. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States. Pediatr Rheumatol Online J. 2021;19(1):143.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"402_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/ard.2005.042143","volume":"65","author":"P Efthimiou","year":"2006","unstructured":"Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still\u2019s disease. Ann Rheum Dis. 2006;65(5):564\u201372.","journal-title":"Ann Rheum Dis"},{"key":"402_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jpeds.2016.05.073","volume":"176","author":"KN Ray","year":"2016","unstructured":"Ray KN, Kahn JM, Miller E, Mehrotra A. Use of adult-trained medical subspecialists by children seeking medical subspecialty care. J Pediatr. 2016;176:173-81.e1.","journal-title":"J Pediatr"},{"issue":"9","key":"402_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3899\/jrheum.120110","volume":"39","author":"T Beukelman","year":"2012","unstructured":"Beukelman T, Ringold S, Davis TE, et al. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol. 2012;39(9):1867\u201374.","journal-title":"J Rheumatol"},{"key":"402_CR19","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/rheumatology\/kez622","volume":"59","author":"A Lenert","year":"2020","unstructured":"Lenert A, Oh G, Ombrello MJ, Kim S. Clinical characteristics and comorbidities in adult-onset Still\u2019s disease using a large US administrative claims database. Rheumatology (Oxford). 2020;59:1725\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"402_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/art.38615","volume":"66","author":"PA Nigrovic","year":"2014","unstructured":"Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2014;66(6):1405\u201313.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"402_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1080\/03009742.2017.1288827","volume":"46","author":"G Horneff","year":"2017","unstructured":"Horneff G, Peitz J, Kekow J, Foell D. Canakinumab for first line steroid-free treatment in a child with systemic-onset juvenile idiopathic arthritis. Scand J Rheumatol. 2017;46(6):500\u20131.","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"402_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63(2):545\u201355.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"402_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/art.38296","volume":"66","author":"SJ Vastert","year":"2014","unstructured":"Vastert SJ, de Jager W, Noordman BJ, et al. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol. 2014;66(4):1034\u201343.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"402_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3899\/jrheum.090952","volume":"36","author":"RA Russo","year":"2009","unstructured":"Russo RA, Katsicas MM. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol. 2009;36(5):1078\u201382.","journal-title":"J Rheumatol"},{"issue":"9","key":"402_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","volume":"55","author":"L Kearsley-Fleet","year":"2016","unstructured":"Kearsley-Fleet L, Davies R, Baildam E, et al. Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers. Rheumatology (Oxford). 2016;55(9):1556\u201365.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00402-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-021-00402-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00402-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:52:31Z","timestamp":1643892751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-021-00402-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00402-z","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}